Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Aurobindo Pharma advances on receiving USFDA approval for Sevelamer Carbonate tablets

19-Jul2017

Aurobindo Pharma advances on receiving USFDA approval for Sevelamer Carbonate tablets

Aurobindo Pharma is currently trading at Rs. 768.40, up by 34.65 points or 4.72% from its previous closing of Rs. 733.75 on the BSE.

The scrip opened at Rs. 771.00 and has touched a high and low of Rs. 794.50 and Rs. 766.10 respectively. So far 2,50,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 06-Oct-2016 and a 52 week low of Rs. 504.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 794.50 and Rs. 691.75 respectively. The current market cap of the company is Rs. 45,051.00 crore.

The promoters holding in the company stood at 51.87%, while Institutions and Non-Institutions held 33.81% and 14.32% respectively.

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture Sevelamer Carbonate tablets 800mg. Sevelamer Carbonate tablets, a therapeutic equivalent generic version of Genzyme's Renvela tablets. The product is being launched immediately.

Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The approved product has an estimated market size of $1.9 billion for the twelve months ending May 2017 according to IMS.

This is the 124th ANDA (including 21 tentative approvals) to be approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 331 ANDA approvals (294 Final approvals including 16 from Aurolife Pharma LLC and 37 tentative approvals) from USFDA.



Related News

View all news

IDBI Bank trades in green on the bourses

IDBI Bank is currently trading at Rs. 56.85, up by 0.35 points or 0.62% from its previous closing of Rs. 56.50 on the BSE.The scrip opened at Rs. 56.50 and has touched a high and low of Rs. 57.45 and Rs.......

Cadila Healthcare trades in green on the bourses

Cadila Healthcare is currently trading at Rs. 345.75, up by 1.05 points or 0.30% from its previous closing of Rs. 344.70 on the BSE.The scrip opened at Rs. 344.35 and has touched a high and low of Rs.......

Zensar Technologies declines on reporting 6% fall in Q3 consolidated net profit

Zensar Technologies is currently trading at Rs. 224.50, down by 8.60 points or 3.69% from its previous closing of Rs. 233.10 on the BSE.The scrip opened at Rs. 227.00 and has touched a high and low of......

Top News

View all news

Coromandel International reports 14% fall in Q3 consolidated net profit

Coromandel International has reported results for third quarter ended December 31, 2018.The company has reported a fall of 15.23% in its net profit at Rs 152.67 crore for the quarter under review as compared......

Bajaj Auto planning to foray into electric vehicles next year

Bajaj Auto is planning to foray into electric vehicles (EV) next year, simultaneously with the migration of its conventional engine vehicles to BS-VI emission norms.The company also plans to launch electric......

Inflame Appliances, Lupin and IDBI Bank to see some action today

Inflame Appliances has set up a new facility to produce Electrical Chimneys & its parts, which can be considered as an 'Make in India' initiative as more than 90% Chimneys are imported from China......